869335-69-3 Usage
Molecular Structure
1H-Pyrrolo[2,3-b]pyridine, 4-chloro-3-fluoro-1-[(4-methylphenyl)sulfonyl]consists of a pyridine ring and a sulfonyl group attached to it.
Functional Groups
The compound contains a 4-chloro-3-fluoro-1-[(4-methylphenyl)sulfonyl]group, which is a sulfonyl derivative of 1H-pyrrolo[2,3-b]pyridine.
Chemical Classification
It is a chemical compound with potential applications in drug discovery and development.
Industry Interest
The compound is of interest to researchers in the pharmaceutical and chemical industries.
Biological Activity
It may have biological activity, which could be relevant for therapeutic purposes.
Synthesis Building Block
The compound could be used as a building block in the synthesis of new compounds for therapeutic purposes.
Further Research
Additional research and testing are needed to fully understand the properties and potential uses of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 869335-69-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,3,3 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 869335-69:
(8*8)+(7*6)+(6*9)+(5*3)+(4*3)+(3*5)+(2*6)+(1*9)=223
223 % 10 = 3
So 869335-69-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H10ClFN2O2S/c1-9-2-4-10(5-3-9)21(19,20)18-8-12(16)13-11(15)6-7-17-14(13)18/h2-8H,1H3
869335-69-3Relevant articles and documents
Substituted Phenylamino-Pyrimidines
-
, (2008/12/04)
The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
SUBSTITUTED PHENYLAMINO-PYRIMIDINES
-
Page/Page column 69-70, (2010/02/14)
The invention relates to substituted phenylamino-pyrimidines, to a method for their production and to their use for producing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular for the treatment of cardiovascular diseases.